Key terms

About TNDM

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TNDM news

Mar 25 5:14pm ET Tandem Diabetes upgraded to Buy at Stifel on strong Mobi adoption Mar 25 5:06pm ET Tandem Diabetes upgraded to Buy from Hold at Stifel Mar 15 7:04am ET Tandem Diabetes price target raised to $31 from $25 at Citi Mar 06 8:55am ET Tandem Diabetes Care (TNDM) Gets a Buy from Lake Street Mar 05 8:47am ET Craig-Hallum Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM) Mar 04 6:29pm ET Tandem Diabetes announces private placement of $250M in convertible senior notes Feb 28 11:14am ET Tandem Diabetes (NASDAQ:TNDM): Investors Look to Innovation to Drive the Stock Higher Feb 25 11:28pm ET Tandem Diabetes Care Holds Steady: A Cautious Outlook Amidst Growth and Competitive Uncertainty Feb 23 3:20am ET Analysts Are Bullish on Top Healthcare Stocks: Intellia Therapeutics (NTLA), Tandem Diabetes Care (TNDM) Feb 22 8:21am ET Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Harmony Biosciences Holdings (HRMY) and Tandem Diabetes Care (TNDM) Feb 22 8:20am ET Tandem Diabetes Care (TNDM) Gets a Hold from Stifel Nicolaus Feb 22 8:11am ET Piper Sandler Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM) Feb 22 7:57am ET Tandem Diabetes Care: Sell Rating Justified by Underwhelming Financials and Market Challenges Feb 22 7:20am ET Tandem Diabetes Care: Steady Growth Prospects and Hold Rating Amid Market Challenges Feb 21 11:50pm ET Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Tandem Diabetes Care (TNDM) Feb 21 4:09pm ET Tandem Diabetes reports Q4 adjusted EPS (46c), consensus (25c) Feb 20 8:45am ET Lake Street Sticks to Their Buy Rating for Tandem Diabetes Care (TNDM) Feb 20 8:39am ET Tandem Diabetes Care (TNDM) Receives a Buy from Craig-Hallum Feb 16 8:50am ET Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM) Feb 15 1:19am ET Hold Rating on Tandem Diabetes Care Amidst Competitive Market and Mobi Launch Uncertainties Feb 05 9:28am ET Tandem Diabetes price target raised to $24 from $17 at Stifel Jan 24 9:54am ET Abbott (NYSE:ABT) Drops on Q4 Numbers Jan 09 9:08am ET Tandem Diabetes Care (TNDM) Gets a Buy from Craig-Hallum

No recent press releases are available for TNDM

TNDM Financials

1-year income & revenue

Key terms

TNDM Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TNDM Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms